Induction of in vitro human macrophage anti-mycobacterium tuberculosis activity: Requirement for IFN-γ and primed lymphocytes

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4490-4499

  Bonecini Almeida, M Gloria ^a,c,d   Chitale, Sadhana ^a   Boutsikakis, Iosif ^a,e   Geng, Jiayuan ^a   Doo, Howard ^a   He, Suhui ^a   Ho, John L ^a,b,f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b New York Affiliate Amer Heart A ^*

^c MINISTÉRIO DA SAÚDE   (Brazil)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e Greek Government

^f Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ARTICLE; BACTERICIDAL ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MACROPHAGE FUNCTION; MORTALITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0032080689     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Raviglione, M. C., D. E. Snider, and A. Koch. 1995. Global epidemiology of tuberculosis. JAMA 273:220.
2. Chapman, S. W., and H. M. Henderson. 1994. New and emerging pathogens -multiple resistant Mycobacterium tuberculosis. Curr. Opinion Infect. Dis. 7:231.
3. Ho, J. L., and L. W. Riley. 1997. Defenses of the lung against tuberculosis. In The Lung Scientific Foundations, 2nd Ed. R. Crystal, J. West, E. Weibel, and P. Barnes, eds. Lippincott-Raven, New York, pp. 2381-2394.
4. Chan, J., and S. H. E. Kaufmann. 1994. Immune mechanisms of protection. 1994. In Tuberculosis: Pathogenesis, Protection, and Control. B. R. Bloom, ed. American Society for Microbiology, Washington, DC, pp. 389-415.
5. + T-cell clones; heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect. Immun. 59:2737.
6. Del Prete, G. F., M. De Carli, M. Ricci, and S. Romagnani. 1991. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity. J. Exp. Med. 174:809.
7. Del Prete, G. F., M. De Carli, C. Mastromauro, R. Biagiotti, D. Macchia, P. Falagiani, M. Ricci, and S. Romagnani. 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocaria canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346.
8. Orme, I. M., A. D. Roberts, J. P. Griffin, and J. S. Abrams. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151:518.
9. Selwyn, P. A., B. M. Sckell, P. Alcabas, G. H. Friedland, R. S. Klein, and E. E. Schoenbaum. 1992. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 269:268.
10. Ho, J. L., R. Badaro, D. Hatzigeogiou, S. G. Reed, and W. D. Johnson, Jr. 1994. Cytokines in the treatment of leishmaniasis: from studies of immunopathology to patient therapy. Biotherapy 7:223.
11. Kaufmann, S. H., C. H. Ladel, and I. E. Flesch. 1995. T-cells and cytokines in interacellular bacterial infections: experiences with Mycobacterium bovis BCG. Ciba Found. Symp. 195:123.
12. Murray, H. W. 1996. Current and future clinical applications of interferon-γ in host antimicrobial defense. Intensive Care Med. 4:(Suppl. 22):S456.
13. Huang, S., W. Hendricks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-receptor. Science 259:1742.
14. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J. Exp. Med. 178:2243.
15. Flynn, J., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
16. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-γ gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941.
17. Jouanguy E., F. Altare, S. Lamhamedi, P. Revy, J.-F. Emile, M. Newport, M. Levin, S. Blanche, A. Fischer, J.-L. Casanova. 1996. Interferon-γ receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N. Engl. J. Med. 335:1956.
18. Hanano R., and S. H. Kaufmann. 1995. Nitric oxide production and mycooacterial growth inhibition by murine alveolar macrophages: the sequence of rIFN-stimulation and Mycobacterium bovis BCG infection determines macrophage activation. Immunol. Lett. 45:23.
19. Rook, G. A. W., J. Tavern, C. Leveton, and J. Steel. 1987. The role of gamma-interferon, vitamin D3 metabolites and tumor necrosis factor in the pathologenesis of tuberculosis. Immunology 67:229.
20. Friedman C. R., G. C. Quinn, B. N. Kreiswirth, N. W. Schluger, D. C. Perlman, N. Salomon, and L. W. Riley. 1997. Widespread dissemination of a single drug-susceptible strain of Mycobacterium tuberculosis in New York City. J. Inject. Dis. 176:478.
21. McCaffrey, T. A., D. J. Falcone, and B. Du. 1992. Transforming growth factor-β1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-01. J. Cell. Physiol. 152:430.
22. McCaffrey, T. A., A. C. Nicholson, P. E. Szabo, M. E. Weksler, and B. B. Weksler. 1988. Aging and arteriosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J. Exp. Med. 167:163.
23. Nicholson S., M. G. Bonecini-Almeida, J. R. Lapa e Silva, C. Nathan, Q.-W. Xie, R. Mumford, J. R. Weidner, J. Calaycay, J.-y. Geng, N. Boechat, C. Linhares, W. Rom, and J. L. Ho. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293.
24. Geller, D. A., C. J. Lowenstein, R. A. Shapiro, A. K. Nussler, M. DiSivio, S. C. Wang, D. K. Nakayama, R. L. Simmons, S. H. Snyder, and T. R. Billiar. 1993. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 90:3491.
25. Chartrain, N. A., D. A. Geller, P. P. Koty, N. F. Sitrin, A. K. Nussler, E. P. Hoffman, T. R. Billiar, N. I. Hutchinson, T. R. Billiar, N. I. Hutchinson, and J. S. Mudgett. 1994. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 269:6765.
26. Toosi, Z., T-G. Young, L. E. Averill, B. D. Hamilton, H. Shiratsuchi, and J. J. Ellner. 1995. Induction of TGF-β by puified protein deriverative of Mycobacterium tuberculosis. Infect. Immun. 63:224.
27. Toossi, Z., P. Gogate, H. Shiratsuchi, T. Young, and J. J. Ellner. 1995. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J. Immunol. 15:465.
28. Dahl, K. E., H. Shiratsuchi, B. D. Hamilton, J. J. Ellner, and Z. Toossi. 1996. Selective induction of transforming growth factor-β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect. Immun. 64:399.
29. De Wall Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. Vries. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulalory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
30. Bogdan, C., Y. Vodovotz, and C. Nathan. 1992. Macrophage deactivation by interleukin-10. J. Exp. Med. 174:1549.
31. Murray, P. J., L. Wang, C. Onufryk, R. I. Tepper, and R. A. Young. 1997. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 158:315.
32. Flesch, I. E., J. H. Hess, I. P. Oswald, and S. H. E. Kaufmann. 1994. Growth inhibition of Mycobacterium bovis by IFN-γ-stimulated macrophages: regulation by endogenous tumor necrosis factor-a and by IL-10. Int. Immunol. 6:693.
33. Zhang, M., Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and P. K. Barnes. 1995. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63:3231.
34. Chomarat, P., M-C. Rissoan, J. Banchereau, and P. Miossec. 1993. Inteferon-γ inhibits interleukin 10 production by monocytes. J. Exp. Med. 177:523.
35. Brunda, M. J. 1994. Interleukin-12. J. Leukocyte Biol. 55:201.
36. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423.
37. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515.
38. Saunders, B. M., Y. Zhan, and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection. Infect. Immun. 63:4011.
39. Nozaki, Y., Y. Hasegawa, S. Ichiyama, I. Nakashima, and K. Shimokata. 1997. Mechanism of nitric oxide-dependent Mycobacterium bovis BCG in human alveolar macrophages. Infect. Immun. 65:3644.
40. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1358.
41. Bonecini-Almeida, M. G., J. R. Lapa e Silva, S. Nicholson, J. Geng, N. Boechat, C. Linhares, L. Rego, and A. L. Kritski. 1997. Inducible nitric oxide synthase and cytokine expression in lung cells from patients with tuberculosis. Am. J. Respir. Crit. Care Med. 155:(Suppl):A441.
42. Ling, P., M. K. Gately, U. Gubler, A. S. Stern, P. Lin, K. Hollfeder, C. Su, Y.-C. E. Pan, and J. Hakimi. 1995. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:116.
43. + IFN-γ-producing cells. J. Immunol. 158:643.
44. Kato, K., O. Shimozato, K. Hosshi, H. Wakimoto, H. Hamada, H. Yagita, and K. Okumura. 1996. Local production of the p40 subunit of interleukin 12 suppresses T helper 1-mediated immune response and prevents allogeneic myoblast rejection. Proc. Natl. Acad. Sci. 93:9085.
45. New York City Health Department. 1995. Health of the City: Focus on Tuberculosis. New York City Health Department, New York, pp. 1-56.
46. Holland, S. M., E. M. Eisenstein, D. B. Kuhns, M. L. Turner, T. A. Fleisher, W. Strober, and J. I. Gallin. 1994. Treatment of refractory disseminated montuberculous mycobacterial infection with interferon gamma. N. Engl. J. Med. 330:1348.
47. Squires, K., S. T. Brown, D. Armstrong, and H. W. Murray. 1992. Interferon-γ treatment for Mycobacterium avium intracellulare bacillemia in patients with AIDS. J. Infect. Dis. 166:686.